Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva.
about
Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malariaHistidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motifPlausibility of HIV-1 Infection of Oral Mucosal Epithelial Cells.Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades.Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatinMultiple components contribute to ability of saliva to inhibit influenza virusesThe mouth: a gateway or a trap for HIV?The four terminal components of the complement system are C-mannosylated on multiple tryptophan residues.Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.Oral transmission of HIV, reality or fiction? An update.Neutrophils Turn Plasma Proteins into Weapons against HIV-1.Systemic and mucosal differences in HIV burden, immune, and therapeutic responsesPrinted Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and SalivaMolecular makeup of HIV-1 envelope protein.CD47 ligation selectively downregulates human interleukin 12 production.Oral mucosal immunity and HIV/SIV infection.The oral mucosa immune environment and oral transmission of HIV/SIV.Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.Innate antiviral immunity of periodontal tissue.Sweating the small stuff: Glycoproteins in human sweat and their unexplored potential for microbial adhesion.Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk.Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.MxA expression induced by α-defensin in healthy human periodontal tissue.Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte.
P2860
Q21131129-C9FEE9AF-E5DE-40C1-955B-187382092457Q24290677-48ECF726-9EFE-4344-8614-AF6B72EC911FQ28262922-2B9267E1-4AB2-447D-9125-419979033D68Q30401195-71E835E3-1B42-4F36-9474-AF5CB98AEA12Q33112684-0CBC45CD-555B-4BFE-BDCF-894E68DF35D3Q33358266-6CE23272-9EE9-46D9-A13D-67B096C1FD32Q33641499-3B44E799-7F74-48B3-B9A3-D04DFFCBBC00Q33745306-A0484CD3-D6D3-4769-B4CB-412404BF3BE4Q33765207-71EB471E-E866-46BF-B228-0D3C195EF6CDQ33874252-3795EBE1-09BC-4D4F-A6EB-F76681F3D9FAQ33879324-55ED40C2-5F1E-4164-9454-44AAA2E1F682Q34258416-805E8859-A820-401F-AC93-C810CDAE6E27Q34341736-FE4E7309-CE58-4353-8A7D-C496549C6311Q34372078-21CDA32B-3EFF-42FD-B2D3-138963D9B49EQ34526020-5378FFBA-1709-43AC-85BE-461A241AD362Q34804975-89A81DE8-69B9-45A8-9208-C58D8BC1E58FQ35190200-7914728C-1D13-4E99-AC7F-E548F8EBAC97Q35686903-233F5FB8-174B-48AA-AB36-D6C52D8FE676Q35888723-93F9709C-748B-4A44-B85A-E69B6AAE20E2Q36375466-632B61D4-5BA4-4124-A3CA-395FD12A5719Q36741771-A86B1436-D01C-4D0F-B3D8-1147A789F61FQ37290154-B0F46B75-F131-4737-8BF6-2408E64F2D39Q37334286-18867FB2-D2BE-45E7-8336-3798A4D63CFDQ37866356-ACBAF32B-5995-4034-BC24-0D8C6B3EBBB9Q38638082-966E3FC9-5FE3-4466-A5E3-9334C5657218Q39402553-56443A9B-E0FE-4F3B-A461-847F4E043D23Q40634411-F100DA21-2A67-40D9-A4F8-E67AEAC59915Q40731786-15AEA16A-366D-4E80-9FE2-DDD7D7E88E17Q45024312-FDE15721-27AF-4028-89EF-E4675FB09B53Q45722167-196DCB31-A5FF-41C8-BBAB-BC766AC0B913Q45723526-6C47DB98-78C0-4F82-8C22-3677B32449F5
P2860
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Identification of a CD36-relat ...... itory factors in human saliva.
@ast
Identification of a CD36-relat ...... itory factors in human saliva.
@en
type
label
Identification of a CD36-relat ...... itory factors in human saliva.
@ast
Identification of a CD36-relat ...... itory factors in human saliva.
@en
prefLabel
Identification of a CD36-relat ...... itory factors in human saliva.
@ast
Identification of a CD36-relat ...... itory factors in human saliva.
@en
P2093
P2860
P356
P1476
Identification of a CD36-relat ...... itory factors in human saliva.
@en
P2093
J Laurence
R L Nachman
R L Silverstein
S F Pearce
P2860
P356
10.1084/JEM.187.1.25
P407
P577
1998-01-01T00:00:00Z